Tag - research

From data to impact: What is it like to be part of ISN research initiatives? 

From global policy tools to community-driven projects and early-career development, ISN's research initiatives offer meaningful opportunities for all professionals committed to advancing kidney care. Whether you're just starting out or looking to broaden your impact, you can grow, collaborate, and drive real impact through ISN-supported research activities. We invited several contributors to share what...

“It’s important to share what we do” — why presenting your work matters   

Presenting an abstract at the ISN World Congress of Nephrology (WCN) is a chance to be part of something bigger — a global exchange of ideas that drives innovation and improves lives.  Join experts and changemakers from around the world to share breakthroughs, spark collaboration, and make your mark on the future of kidney care.  Showcase...

Build better kidney health data – one step at a time with SharE‑RR Toolkit 

Reliable kidney health data is critical to improving care, but where do you begin?  The ISN SharE-RR Toolkit is your free step-by-step guide to building or strengthening a kidney health registry. Whether your focus is on chronic kidney disease, acute kidney injury, dialysis, or transplantation, this practical resource walks you through everything from feasibility to...

Explore the latest ISN Global Trials Focus selections featuring a “Trial of the month” on the effect of dapagliflozin in patients with ADPKD receiving tolvaptan

ISN-ACT Global Trials Focus editorial team member Michele Provenzano summarizes the design and outcomes of the latest "Trial of the month" featured in ISN-ACT Global Trials Focus. Trial of the month: DAPA-tolvaptan: First trial of SGLT2 inhibition in ADPKD with background tolvaptan therapy Open-label, randomized, controlled, crossover trial on the effect of dapagliflozin in patients with ADPKD receiving tolvaptan Uchiyama...

ISN Journal summaries on the SONG initiative and public data in research 

Kidney International®  The Standardized Outcomes in Nephrology (SONG) initiative: A decade of harmonizing patient voices and research in kidney disease   The authors of this editorial highlight how research on chronic kidney disease has been hindered by inconsistent and often patient-irrelevant reporting of outcomes.   This challenge prompted the launch of the global Standardized Outcomes in Nephrology (SONG) initiative...

Sharpen your scientific writing skills: Apply now for the ISN Scientific Writing Course in Mombasa 

You may have important data, but unless your research is communicated clearly and effectively, its impact is limited. The ISN Scientific Writing Course (SWC) is designed to help you turn your research into clear, compelling scientific writing that gets published and makes an impact.   Applications are now open for ISN members for this year’s Africa-focused...

Take a step in the right direction: Apply as an ISN Mentee by July 1 

Anisha Gerber, a pediatric nephrologist and assistant professor at the University of Virginia, became a mentee in 2023 while completing her fellowship. She was matched with Nivedita Kamath at St. John's Medical College in Bangalore, India.   Apply to be a mentee by July 1  According to Anisha, the mentorship partnership has been instrumental in advancing her...

Award-winning impact from an ISN Mentorship pairing 

ISN Mentee Felix-Mihai Maralescu  Apply to the ISN Mentorship Program as a mentee by July 1  Felix-Mihai Maralescu, a young nephrologist from the Romanian city of Santana, was looking for research guidance when he was accepted into the ISN Mentorship Program. What he gained was a career-defining milestone!  Apply to the ISN Mentorship Program  Paired with Jochen Raimann...

ISN-GKHA 2023 findings feature in PLOS Global Public Health roundtable 

PLOS Global Public Health recently hosted a roundtable with the lead authors of ISN-Global Kidney Health Atlas (ISN-GKHA) articles they published earlier this year.  The authors highlight key insights from their research, which examined disparities in the availability, affordability, quality, and access to kidney care services across countries categorized by World Bank income group classifications.   Watch...

Optimize trial integrity: New SOP and ethics resources in the ISN-ACT Clinical Trials Toolkit 

The ISN-ACT Toolkit now features a section on Standard Operating Procedures (SOPs) in clinical trials to help improve clarity, consistency, and traceability in clinical trial processes.   Access the SOP section of the ISN Clinical Trials Toolkit here  Contributed by ISN-Advancing Clinical Trials Committee member Paula Andrea Marioli (Argentina) and colleagues, the section includes:  Suggested SOP format – a structured guide...

PLOS articles spotlight ISN-GKHA 2023 findings on the international state of kidney care

PLOS Global Public Health recently published a series of articles using data from the third edition of the ISN-Global Kidney Health Atlas (ISN-GKHA), exploring gaps in availability, affordability, quality, and access to kidney care services across countries by World Bank income group classifications.  Read the individual papers in PLOS Global Public Health:   “Landscape of kidney replacement...

ISN’s Global Kidney Health Atlas 2023 Data Addresses Kidney Care Gaps in Resource-limited Settings

PLOS Global Public Health recently published a series of articles using data from the third edition of the ISN-Global Kidney Health Atlas (ISN-GKHA), exploring gaps in availability, affordability, quality, and access to kidney care services across countries by World Bank income group classifications. Read the individual papers in PLOS Global Public Health: “Landscape of Kidney Replacement...

ISN Journal Summaries on Clinical Practice Guideline for ADPKD and Mitochondrial Function in Diabetic Kidney Disease

Kidney International® KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Executive Summary The KDIGO 2025 Clinical Practice Guideline for ADPKD is the first global guideline on the evaluation, management, and treatment of this genetic disorder, focusing on areas such as diagnosis, kidney manifestations, disease progression, and extrarenal...

Meet the KI-ISN Early-Career Researchers and ISN-KI Editorial Fellows!

The ISN-KI/KIR Editorial Fellows Session: The Best of 2024/25 Articles will take place at WCN’25 on Saturday, February 8, 2025, from 9:45-11:15 a.m.  KI-ISN Early-Career Researcher Awardees and ISN-KI Editorial Fellows will be honored during this session. KI-ISN Early-Career Researcher Awards honor exceptional basic and clinical science research published in Kidney International® (KI) in the...

Strengthening Global Nephrology: Highlights From Taiwan 

In December 2024, the ISN conducted a Scientific Writing Course (SWC) in Taiwan, co-hosted and co-supported by the Taiwan Society of Nephrology (TSN). The course equipped participants with the tools and confidence to craft high-quality research publications. Delegates follow the ISN SWC course with tailored guidance from course faculty Testimonials from participants highlight the course's value: "The...

ISN Journal Summaries on Hypertension-avoidance Strategies and Age-based GFR    

Kidney International®  A Sub-study of the POISE-3 Randomized Trial Examined Effects of a Perioperative Hypotension-avoidance Strategy Versus a Hypertension-avoidance Strategy on the Risk of Acute Kidney Injury  This sub-study of the POISE-3 trial investigated whether a strategy to prevent low blood pressure during surgery could reduce the risk of acute kidney injury (AKI).   Researchers randomized 7,307 patients...

Celebrating ISN’s 2024 Publications: Driving Kidney Research for Better Patient Outcomes 

As we step into 2025, we reflect on the impactful ISN-led research of 2024. These studies deepen our understanding of kidney health and advance global kidney care as a health priority. Below, we highlight some of the year’s key contributions:    An Update on the Global Disparities in Kidney Disease Burden and Care Across World Countries...

Exploring Groundbreaking Research: Introducing High-impact Trials at WCN’25

The High-impact Trials (HIT) sessions at WCN'25 promise exciting insights and findings from cutting-edge research in kidney care and related fields, including: The FLOW Trial investigating semaglutide's impact on kidney outcomes and cardiovascular safety The REGENCY Trial on improving renal response rates in lupus nephritis with Obinutuzumab The ZEUS Trial evaluating ziltivekimab's potential for cardiovascular protection in...